全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

中西医亚实性肺结节研究进展
Advances in Research on Subsolid Pulmonary Nodules in Traditional Chinese and Western Medicine

DOI: 10.12677/jcpm.2025.42263, PP. 945-954

Keywords: 亚实性肺结节,正气亏虚,痰凝,血瘀
Subsolid Pulmonary Nodules
, Deficiency of Vital Qi, Phlegm Coagulation, Blood Stasis

Full-Text   Cite this paper   Add to My Lib

Abstract:

近几年的肺结节检出率因影像学技术的提高和国民健康意识的提高而快速增长,现代医学对肺结节的治病遵循随访观察、外科手术的原则,而亚实性肺结节恶性风险高但进展缓慢,受到越来越多的重视,影像学随访频繁,可能使患者焦虑加重,导致诊疗过度,而根治性手术的过早实施,也可能会造成介入过度。在此临床决策困境下,中医药散结展现出独特的临床优势,患者趋向于中医疗法。在中医治疗肺结节方面,各家都有多年的临床经验和独到的见解,亚实性肺结节通常被认为是以正气亏虚为本虚,以气滞、痰凝、血瘀、毒聚等为其标实,在治疗上需要根据证型辨证论治标本兼治,以化痰散结、活血通络、行气祛湿、通阳散结等治其标实,在扶助正气治疗本虚的基础上治疗肺结节。
In recent years, the detection rate of pulmonary nodules has surged significantly due to advancements in imaging technology and heightened public health awareness. Modern medicine typically manages pulmonary nodules through follow-up observation and surgical intervention. However, subsolid pulmonary nodules, which carry a high malignant risk yet progress slowly, have garnered increasing attention. Frequent imaging follow-ups may exacerbate patient anxiety, leading to overdiagnosis, while premature radical surgery risks excessive intervention. Amidst this clinical dilemma, Traditional Chinese Medicine has demonstrated unique advantages in nodule-resolving therapies, with growing patient preference for TCM approaches. In TCM practice, subsolid pulmonary nodules are generally conceptualized as rooted in deficiency of vital Qi, with surface manifestations such as Qi stagnation, phlegm coagulation, blood stasis, and toxin accumulation. Treatment emphasizes syndrome differentiation and holistic management, targeting both the root (reinforcing vital Qi) and the manifestations (resolving phlegm, dispelling stasis, regulating Qi, eliminating dampness, and dispersing nodules). Therapies like phlegm-dissolving, stasis-removing, Qi-activating, and Yang-unblocking methods are employed to address surface pathologies, while concurrently strengthening the body’s foundational vitality to treat pulmonary nodules comprehensively.

References

[1]  中华医学会呼吸病学分会肺癌学组, 中国肺癌防治联盟专家组. 肺结节诊治中国专家共识(2018年版) [J]. 中华结核和呼吸杂志, 2018, 41(10): 763-771.
[2]  史景云, 孙奋勇, 刘海鹏, 等. 肺部多发磨玻璃结节中西医结合防治一体化专家共识[J]. 肿瘤, 2022, 42(7): 451-465.
[3]  de Koning, H.J., van der Aalst, C.M., de Jong, P.A., Scholten, E.T., Nackaerts, K., Heuvelmans, M.A., et al. (2020) Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. New England Journal of Medicine, 382, 503-513.
https://doi.org/10.1056/nejmoa1911793
[4]  吴强, 张祥海, 袁海军. CD147、MUC5ac在周围型非小细胞肺癌中的表达及与CT征象的相关性[J]. 中国医师杂志, 2017, 19(4): 549-551.
[5]  Heuvelmans, M.A., Walter, J.E., Peters, R.B., Bock, G.H.D., Yousaf-Khan, U., Aalst, C.M.V.D., et al. (2017) Relationship between Nodule Count and Lung Cancer Probability in Baseline CT Lung Cancer Screening: The NELSON Study. Lung Cancer, 113, 45-50.
https://doi.org/10.1016/j.lungcan.2017.08.023
[6]  Eguchi, T., Bains, S., Lee, M., Tan, K.S., Hristov, B., Buitrago, D.H., et al. (2017) Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Patients with Stage I Non-Small-Cell Lung Cancer: A Competing Risks Analysis. Journal of Clinical Oncology, 35, 281-290.
https://doi.org/10.1200/jco.2016.69.0834
[7]  庞新来. 观察临床因素与CT影像学特征在判断孤立性肺结节良、恶性中的应用价值[J]. 医学食疗与健康, 2020(15): 182-183.
[8]  中华医学会呼吸病学分会. 早期肺癌诊断中国专家共识(2023年版) [J]. 中华结核和呼吸杂志, 2023, 46(1): 1-18.
[9]  刘浩雷, 尹格, 向毅, 等. 不同恶性概率预测模型在亚实性肺结节患者中的验证性研究[J]. 现代医药卫生, 2021, 37(24): 4246-4248.
[10]  MacMahon, H., Naidich, D.P., Goo, J.M., Lee, K.S., Leung, A.N.C., Mayo, J.R., et al. (2017) Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017. Radiology, 284, 228-243.
https://doi.org/10.1148/radiol.2017161659
[11]  Chen, D., Kang, P., Tao, S., Li, Q., Wang, R. and Tan, Q. (2021) Cost-Effectiveness Evaluation of Robotic-Assisted Thoracoscopic Surgery versus Open Thoracotomy and Video-Assisted Thoracoscopic Surgery for Operable Non-Small Cell Lung Cancer. Lung Cancer, 153, 99-107.
https://doi.org/10.1016/j.lungcan.2020.12.033
[12]  Hernandez-Vaquero, D., Vigil-Escalera, C., Pérez-Méndez, I., Gutiérrez, A., Avanzas, P., Wei, Y., et al. (2021) Survival after Thoracoscopic Surgery or Open Lobectomy: Systematic Review and Meta-Analysis. The Annals of Thoracic Surgery, 111, 302-313.
https://doi.org/10.1016/j.athoracsur.2020.05.144
[13]  Jiang, Y., Su, Z., Liang, H., Liu, J., Liang, W. and He, J. (2020) Video-Assisted Thoracoscopy for Lung Cancer: Who Is the Future of Thoracic Surgery? Journal of Thoracic Disease, 12, 4427-4433.
https://doi.org/10.21037/jtd-20-1116
[14]  Nakazawa, S., Shimizu, K., Mogi, A. and Kuwano, H. (2018) VATS Segmentectomy: Past, Present, and Future. General Thoracic and Cardiovascular Surgery, 66, 81-90.
https://doi.org/10.1007/s11748-017-0878-6
[15]  姜格宁, 陈昶, 朱余明, 等. 上海市肺科医院磨玻璃结节早期肺腺癌的诊疗共识(第一版) [J]. 中国肺癌杂志, 2018, 21(3): 147-159.
[16]  Liu, J., Liu, X., Yan, B., Xue, Y., Han, X., Li, H., et al. (2018) Pulmonary Multiple Nodules. Chinese Medical Journal, 131, 1999-2001.
https://doi.org/10.4103/0366-6999.238136
[17]  Kozower, B.D., Larner, J.M., Detterbeck, F.C. and Jones, D.R. (2013) Special Treatment Issues in Non-Small Cell Lung Cancer. Chest, 143, E369S-E399S.
https://doi.org/10.1378/chest.12-2362
[18]  赫捷, 李霓, 陈万青, 等. 中国肺癌筛查与早诊早治指南(2021, 北京) [J]. 中国肿瘤, 2021, 30(2): 81-111.
[19]  Henschke, C.I., Yip, R., Smith, J.P., Wolf, A.S., Flores, R.M., Liang, M., et al. (2016) CT Screening for Lung Cancer: Part-Solid Nodules in Baseline and Annual Repeat Rounds. American Journal of Roentgenology, 207, 1176-1184.
https://doi.org/10.2214/ajr.16.16043
[20]  叶欣, 王俊, 危志刚, 等. 热消融治疗肺部亚实性结节专家共识(2021年版) [J]. 中国肺癌杂志, 2021, 24(5): 305-322.
[21]  Ye, X., Fan, W., Wang, Z., et al. (2021) Expert Consensus for Thermal Ablation of Pulmonary Subsolid Nodules. Chinese Journal of Lung Cancer, 24, 305-322.
[22]  王钰, 刘悦, 李佳, 等. 窠囊理论发展与临床应用探讨[J]. 辽宁中医药大学学报, 2020, 22(6): 72-74.
[23]  侯秋月, 史锁芳. 史锁芳运用疏肝理气、化痰散结法治疗肺小结节经验[J]. 中华中医药杂志, 2019, 34(10): 4652-4654.
[24]  李星慧, 林雪娟. 从“痰” “瘀”探讨支气管哮喘缓解期的病理因素[J]. 福建中医药, 2020, 51(4): 57-59.
[25]  徐佳仪. 肺部小结节患者中医体质分布规律探析[D]: [硕士学位论文]. 杭州: 浙江中医药大学, 2019.
[26]  李志明, 王芬, 李仝, 等. 从“痰、瘀、毒、虚”分析中医药逆转肺癌化疗耐药的治疗思路[J]. 中医学报, 2025: 1-13.
http://kns.cnki.net/kcms/detail/41.1411.R.20250225.0856.010.html, 2025-04-07.
[27]  李梦乾, 张晓梅, 胡家蕊. 从正虚痰瘀论治肺结节[J]. 光明中医, 2022, 37(3): 357-360.
[28]  祝海毅, 曹晋, 陈勇, 等. 基于关联规则分析罗玲治疗肺结节组方规律[J]. 实用中医内科杂志, 2020, 34(8): 7-11.
[29]  魏华民, 朱瑞丽, 刘瑞, 等. 从痰瘀窠囊论治肺结节[J]. 世界中医药, 2018, 13(11): 2701-2705, 2708.
[30]  朱丽娜, 刘丽坤. 中医治疗孤立性肺结节思路探讨[J]. 亚太传统医药, 2019, 15(2): 79-81.
[31]  洪海都, 刘城鑫, 吴鹏, 等. 刘小虹辨治肺结节中医特色探析[J]. 中国中医基础医学杂志, 2020, 26(4): 539-541.
[32]  李烨, 舒鹏. 基于“六郁”理论辨治亚实性肺结节[J]. 中医药学报, 2023, 51(5): 17-20.
[33]  刘燕鸿, 奚肇庆. 奚肇庆教授从气虚论治术后肺结节经验[J]. 福建中医药, 2022, 53(9): 52-53.
[34]  吴琴, 范伏元, 王伟. 范伏元教授治疗肺磨玻璃结节经验[J]. 亚太传统医药, 2021, 17(3): 113-116.
[35]  刘莹, 王乐, 李皓月, 等. 曹洪欣教授治疗肺磨玻璃结节经验[J]. 世界中西医结合杂志, 2021, 16(3): 450-453.
[36]  褚雪镭, 陈美池, 李颖, 等. 海花调肺方治疗早期肺癌术后伴肺部多发亚厘米磨玻璃结节疗效观察[J]. 中药新药与临床药理, 2023, 34(8): 1151-1155.
[37]  李玥, 胡佳奇, 胡越, 等. 中医药辨证治疗亚实性肺结节的实用性随机对照研究[J]. 肿瘤防治研究, 2024, 51(5): 373-379.
[38]  Chuang, H., Yun, L., Jiang-Ping, L., Li, L., Liang-Shan, L., Ting-Yuan, L., et al. (2024) Predicting Subsolid Pulmonary Nodules before Percutaneous Needle Biopsy: A Comparison of Artificial Neural Network and Biopsy Results. Clinical Radiology, 79, e453-e461.
[39]  顾亚峰, 李琼, 刘士远. 肺亚实性结节CT定量测量的研究进展[J]. 中华放射学杂志, 2017, 51(4): 317-320.
[40]  申磊磊, 刘有, 宁浩勇, 等. 第8版肺癌TNM分期亚实性结节T分期建议方案的验证[J]. 中华胸部外科电子杂志, 2024, 11(1): 40-52.
[41]  Su, H., Chen, L., Wu, J., Cheng, Z., Li, J., Ren, Y., et al. (2025) Proteogenomic Characterization Reveals Tumorigenesis and Progression of Lung Cancer Manifested as Subsolid Nodules. Nature Communications, 16, Article No. 2414.
https://doi.org/10.1038/s41467-025-57364-x

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133